Novan Investor Relations Material
Latest events
Q1 2023
Novan
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Novan Inc
Access all reports
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. It is engaged in developing nitric oxide-based therapeutics for the treatment of skin pathologies, including acne vulgaris and other inflammatory conditions such as psoriasis, atopic dermatitis, wound healing, endometriosis, hidradenitis suppurativa (HS) and eczema; and microbial infections in dermatology such as MRSA infections. The company's product candidate pipeline consists of two Phase 3 clinical stage candidates: M834 for HS and an acne treatment; as well as a Phase 2 clinical candidate for topical fungal infections.
Latest articles
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
John Elkann: Leading Stellantis, Ferrari, and Exor to New Heights
As the Chairman of Stellantis and Ferrari and CEO of Exor, John Elkann is arguably the most influential person in the global automotive sector.
26 Mar 2024
Ticker symbol
Country
🇺🇸 United States